Tech Center 1700 • Art Units: 1674 1681 1797
This examiner grants 0% of resolved cases
Brandon Ross Schwechter is an examiner in Tech Center 1700 and Art Unit 1674. He has 1 resolved case. The allowance rate for this examiner is 0.0 percent. This 0.0 percent rate reflects the outcome of the single case in the current data set. Practitioners should note that with only 1 resolved case, the statistical significance of this rate is limited.
The interview lift is 0.0 percent. This value indicates that there is no recorded change in allowance probability associated with interviews in this examiner's history. Because the allowance rate is already stated, the interview lift provides a consistent reflection of the current case outcomes. This suggests that applicants may need to wait for more data to evaluate the effectiveness of oral discussions.
The median days to allowance is 1229. This 1229-day figure represents the time elapsed for the prosecution of the cases in this docket. Applicants can use this 1229-day duration as a preliminary estimate for the length of the patent acquisition process. The combination of 1 resolved case and a 1229-day median provides an initial look at the prosecution environment in Art Unit 1674.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18036602 | USE OF ANNEXIN V TO IMPROVE THE PURITY, SOLUBILITY AND LONG-TERM STABILITY OF PHAGE SUSPENSIONS | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 18355108 | Macrophage Stimulating 1 Receptor (MST1R) Variants And Uses Thereof | Final Rejection | Regeneron Pharmaceuticals, Inc. |
| 18262543 | PEPTIDE FOR PREVENTING AND TREATING FIBROSIS | Non-Final OA | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION |
| 17732347 | MULTISPECIFIC ANTIBODIES | Non-Final OA | Hoffmann-La Roche Inc. |
| 18557834 | COMPOSITIONS AND METHODS OF TREATING SEPSIS IN PATIENTS USING ANTI-LIGHT ANTIBODIES | Non-Final OA | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA |
| 18173358 | COMPOSITIONS AND METHODS FOR PROMOTING HAIR GROWTH | Non-Final OA | Duke University |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy